Commentary on “Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: a European and East Asian Populations-Based Mendelian Randomization Analysis”
Cancer Research and Treatment · 15.07.2026 · 58 (3) · 1022-1023
DOI: 10.4143/crt.2026.0076 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Research and Treatment, erschienen am 15.07.2026. Verfasst von Fei Ying und 2 weiteren Autor:innen. Beteiligte Einrichtung: Qingdao Hongdao People's Hospital, Qingdao, China. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
We read with great interest the recent article by Chen and colleagues investigating the bidirectional causal relationship between gastric cancer (GC) and lung cancer (LC) using a two-sample summary-level Mendelian randomization (MR) framework [1]. The authors’ rigorous analytical approach represents an important contribution to understanding shared genetic susceptibility between these malignancies. We wish to offer several suggestions that, while not directly implementable within the published two-sample MR framework, may inform the design of complementary future investigations. First, the current study evaluates GC and LC as unified phenotypes, yet both encompass histological and molecular sub-types with potentially distinct genetic architectures. As a future research direction contingent upon the development of sub-type-resolved genome-wide association study (GWAS), stratified MR analyses—reported in accordance with the STROBE-MR guidelines—could reveal heterogeneous causal effects [2]. For GC, comparing intestinal-type versus diffuse-type, or molecular subtypes such as microsatellite instability–high versus microsatellite stable cases, might distinguish inflammation-driven carcinogenesis from epithelial-mesenchymal transition pathways. For LC, MR stratified by driver mutation status—such as EGFR (epidermal growth factor receptor)-mutant LC (prevalent among East Asian never-smokers) versus KRAS -mutant LC—could clarify pathway-specific relationships. We emphasize, however, that the current feasibility of such analyses is constrained by the limited availability and statistical power of subtype-and mutation-defined GWAS summary statistics, and that genome-wide significant, strongly relevant instruments (F-statistic > 10) for these strata remain scarce. Realization of this agenda will require coordinated international consortium efforts to expand subtype-specific GWAS sample sizes. Second, we note the authors’ transparent acknowledgment that fewer
Autor:innen und Institutionen
- Qingdao Hongdao People's Hospital, Qingdao, China.
- Qingdao Hongdao People's Hospital, Qingdao, China. wt2k87j@163.com.
Zitieren
APA
Ying, F., Zhao, X., & Wang, T. (2026). Commentary on “Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: a European and East Asian Populations-Based Mendelian Randomization Analysis”. Cancer Research and Treatment, 58(3), 1022-1023. https://doi.org/10.4143/crt.2026.0076
Vancouver
Ying F, Zhao X, Wang T. Commentary on “Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: a European and East Asian Populations-Based Mendelian Randomization Analysis”. Cancer Research and Treatment. 2026;58(3):1022-1023. doi:10.4143/crt.2026.0076
BibTeX
@article{Ying2026,
author = {Ying, Fei and Zhao, Xuan and Wang, Tao},
title = {Commentary on “Deciphering the Risk of Developing Lung Cancer after the Diagnosis of Gastric Cancer with Genetic Evidence: a European and East Asian Populations-Based Mendelian Randomization Analysis”},
journal = {Cancer Research and Treatment},
year = {2026},
volume = {58},
number = {3},
pages = {1022--1023},
doi = {10.4143/crt.2026.0076}
}
EUVIMED